Bgm (BGM) Enterprise Value (2019 - 2025)
Bgm's (BGM) quarterly Enterprise Value came in at -$8.8 million in Q3 2025, up 14.85% year-on-year from -$7.7 million in Q3 2024, and down 19.08% on a QoQ basis from -$7.4 million in Q1 2025.
Bgm (BGM) Enterprise Value (2019 - 2025) Analysis & Trends
Bgm (BGM) has 7 years of Enterprise Value data on file, last reported at -$8.8 million in Q3 2025.
- On a quarterly basis, Enterprise Value rose 14.85% year-over-year to -$8.8 million in Q3 2025; TTM through Sep 2025 was -$8.8 million, a 14.85% increase from a year earlier, with the FY2025 full-year figure at -$8.8 million, up 14.85% from the prior year.
- Enterprise Value for Q3 2025 stood at -$8.8 million, down from -$7.4 million in the prior quarter.
- Over the last five years, Enterprise Value for BGM reached as high as $1055.0 billion in Q1 2023 and fell as low as -$20000.0 billion in Q1 2021.
- Historically, Enterprise Value has averaged -$2186.5 billion across 5 years, with a median of -$9.8 million in 2024.
- Across the five-year window, Enterprise Value soared 136.13% in 2023 and tumbled 100.0% in 2024, its largest moves.
- Year by year, Enterprise Value stood at -$10.8 million in 2021, then fell by 21.02% to -$13.1 million in 2022, then jumped by 47.07% to -$6.9 million in 2023, then slumped by 49.42% to -$10.3 million in 2024, then gained by 14.85% to -$8.8 million in 2025.
- Per Business Quant data, the three most recent Enterprise Value figures were -$8.8 million in Q3 2025, -$7.4 million in Q1 2025, and -$10.3 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.99 Bn | 32.25 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | -2.15 Bn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | -3.97 Mn |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Bgm | 32.91 Mn | 23.09 Mn | - | -8.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -8.80 Mn |
| Mar 31, 2025 | -7.39 Mn |
| Sep 30, 2024 | -10.34 Mn |
| Mar 31, 2024 | -9.30 Mn |
| Sep 30, 2023 | -6.92 Mn |
| Mar 31, 2023 | 1,054.98 Bn |
| Sep 30, 2022 | -13.07 Mn |
| Mar 31, 2022 | -2,920.05 Bn |
| Sep 30, 2021 | -10.80 Mn |
| Mar 31, 2021 | -20,000.00 Bn |
| Sep 30, 2020 | -9.12 Mn |
| Sep 30, 2019 | -1.85 Mn |